Vicentra raises €11.2M Series C+ round
8 January 2026· Utrecht, The Netherlands· health, medical_devices, software_hardware, b2c, diabetes_management, insulin_delivery
ViCentra is expanding production and international operations while advancing its Kaleido insulin patch pump to support diabetes management and strengthen its position in the growing insulin delivery market.
Investors
LeadROM Utrecht Region
Also participating
Venturing TechInnovation Industries
About Vicentra
Key People
Tom ArnoldChief Executive Officer
Tim OakesChief Technology Officer and Co-founder
Leo TooleChief Financial Officer
Stage
Series C+
Headquarters
Utrecht, The Netherlands
Founded
2013
Team Size
201–500
Sectors
healthmedical_devicessoftware_hardwareb2cdiabetes_managementinsulin_delivery